Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-26-082011

Options or other derivatives

  • Director acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Swirsky Douglas J Director 2026-07-07 Grant or award · Stock option (right to buy) +37,500 37,500 D
Loading xslF345X06/tm2620095-3_4seq1.xml…